$SGMO (3)

1. Pfizer $PFE : scenario

SB-525 new data is strong, clearly surpassing $BMRN #valrox and setting up 525 as the best-in-class HemA tx. PFE sees the GT platform as a winner &amp; jumps the mkt on the bigger read-thru tx still in the pipeline: #Fabry, buys SGMO outright.